Evidence map›Paper›PMID 42097300›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2026

Integrating experimental data and mechanistic modeling to assess potential lead exposure from tampon use.

Corie A Ellison, Patrick R Doyle, Christina A Haven, Denise M McClenathan, Cindy M Obringer, Kara E Woeller

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Corie A EllisonGlobal Product Stewardship, The Procter & Gamble Company, Mason, OH 45040, United States.
Patrick R DoyleCorporate Functions Analytical, The Procter & Gamble Company, Mason, OH 45040, United States.
Christina A HavenCorporate Functions Analytical, The Procter & Gamble Company, Mason, OH 45040, United States.
Denise M McClenathanCorporate Functions Analytical, The Procter & Gamble Company, Mason, OH 45040, United States.
Cindy M ObringerGlobal Product Stewardship, The Procter & Gamble Company, Mason, OH 45040, United States.
Kara E WoellerGlobal Product Stewardship, The Procter & Gamble Company, Cincinnati, OH 45232, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trace levels of lead (Pb) have been reported in tampons, prompting concerns about potential exposure during menstrual product use. However, the presence of a chemical in a product does not necessarily translate to biologically relevant exposure. In this study, we characterized the distribution and binding of Pb in menstrual fluid and developed a deterministic, compartmental mass-balance model to evaluate the release and fate of Pb that may be present as an inadvertent trace impurity in tampons. Our experimental measurements demonstrated that Pb preferentially partitions to the red blood cell (RBC) fraction of menstrual fluid. The remaining Pb was distributed in the plasma fraction, where the majority was protein-bound. These distribution and binding characteristics were broadly comparable to those reported for systemic blood. Utilizing these data, a mechanistic model was parameterized to describe the release of Pb from a tampon into menstrual fluid, partitioning between menstrual fluid compartments, reabsorption into the tampon during fluid uptake, and potential permeation across vaginal tissue. Under the conservative assumptions evaluated here, model simulations for a 4-h tampon wear scenario predicted that the majority of theoretically released Pb is reabsorbed into the tampon, with only a very small fraction (<1 ng; <0.3%) available for potential absorption into vaginal tissue. Sensitivity and alternative release scenario analyses demonstrated that predicted tissue uptake remained minimal across various plausible conditions. Collectively, these findings underscore the importance of integrating chemical presence data with physiological context and mechanistic modeling to inform exposure assessment and support science-based evaluation of product safety.

Indexed as

LeadMenstrual Hygiene ProductsModels, BiologicalErythrocytesFemaleHumansVaginaLeadexposure refinementmechanistic modelingmetalsplasma protein bindingtampons

Identifiers

PMID42097300
PMCPMC13215380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.